P-glycoprotein function and expression during obstructive cholestasis in rats

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 5, 2008, Pages 404-412

  Micuda, Stanislav ^a   Brcakova, Eva ^a   Fuksa, Leos ^a   Cermanova, Jolana ^a   Osterreicher, Jan ^c   Hroch, Milos ^a   Mokry, Jaroslav ^a   Pejchal, Jaroslav ^c   Martinkova, Jirina ^a   Staud, Frantisek ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^c UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Acute and chronic extrahepatic cholestasis; mdr1; P glycoprotein; Rhodamine 123

Indexed keywords

GLYCOPROTEIN P; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; BILE DUCT OBSTRUCTION; BILE FLOW; BILIARY EXCRETION; CHOLESTASIS; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STEADY STATE; UPREGULATION; URINALYSIS; URINARY EXCRETION;

ACUTE DISEASE; ANIMALS; BILE; BILIRUBIN; BLOTTING, WESTERN; CHOLESTASIS, EXTRAHEPATIC; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; KIDNEY; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; RHODAMINE 123;

EID: 42149146771     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f471bf     Document Type: Article

References (47)

1. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003; 55:3-29.
2. Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H, et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998; 28:1637-1644.
3. Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 2003; 200:553-560.
4. Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, et al. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 2003; 38:717-727.
5. Zollner G, Wagner M, Fickert P, Silbert D, Fuchsbichler A, Zatloukal K, et al. Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int 2005; 25:367-379.
6. Hartmann G, Vassileva V, Piquette-Miller M. Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Drug Metab Dispos 2005; 33:820-828.
7. Hidemura K, Zhao YL, Ito K, Nakao A, Tatsumi Y, Kanazawa H, et al. Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2. Antimicrob Agents Chemother 2003; 47:1636-1642.
8. Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol 2005; 43:342-357.
9. Lee J, Boyer JL. Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders. Semin Liver Dis 2000; 20:373-384.
10. Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 2001; 34:351-359.
11. Tanaka Y, Kobayashi Y, Gabazza EC, Higuchi K, Kamisako T, Kuroda M, et al. Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice. Am J Physiol Gastrointest Liver Physiol 2002; 282:G656-G662.
12. Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA, Thorgeirsson SS. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 1993; 17:854-860.
13. Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997; 113:255-264.
14. Lee JM, Trauner M, Soroka CJ, Stieger B, Meier PJ, Boyer JL. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology 2000; 118:163-172.
15. Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. J Hepatol 1996; 25:349-361.
16. Micuda S, Fuksa L, Mundlova L, Osterreicher J, Mokry J, Cermanova J, et al. Morphological and functional changes of P-glycoprotein during dexamethasone induced hepatomegaly. Clin Exp Pharmacol Physiol 2007; 34:296-303.
17. Lee J, Azzaroli F, Wang L, Soroka CJ, Gigliozzi A, Setchell KD, et al. Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology 2001; 121:1473-1484.
18. Kanno K, Tazuma S, Niida S, Chayama K. Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction. Hepatol Res 2003; 26:157-163.
19. van Montfoort JE, Muller M, Groothuis GM, Meijer DK, Koepsell H, Meier PJ. Comparison of 'type I' and 'type II' organic cation transport by organic cation transporters and organic anion-transporting polypeptides. J Pharmacol Exp Ther 2001; 298:110-115.
20. Ando H, Nishio Y, Ito K, Nakao A, Wang L, Zhao YL, et al. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob Agents Chemother 2001; 45:3462-3467.
21. Kageyama M, Fukushima K, Togawa T, Fujimoto K, Taki M, Nishimura A, et al. Relationship between excretion clearance of rhodamine 123 and Pglycoprotein (Pgp) expression induced by representative Pgp inducers. Biol Pharm Bull 2006; 29:779-784.
22. Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metab Dispos 2001; 29:145-151.
23. Eytan GD, Regev R, Oren G, Assaraf YG. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Biol Chem 1996; 271:12897-12902.
24. van der Sandt I, Blom-Roosemalen MC, de Boer AG, Breimer DD. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur J Pharm Sci 2000; 11:207-214.
25. Denk GU, Soroka CJ, Mennone A, Koepsell H, Beuers U, Boyer JL. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology 2004; 39:1382-1389.
26. Chen CY, Shiesh SC, Wu MC, Lin XZ. The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets. Am J Gastroenterol 1999; 94:2408-2411.
27. Kawaguchi T, Sakisaka S, Sata M, Mori M, Tanikawa K. Different lobular distributions of altered hepatocyte tight junctions in rat models of intrahepatic and extrahepatic cholestasis. Hepatology 1999; 29:205-216.
28. Zollner G, Trauner M. Molecular mechanisms of cholestasis. Wien Med Wochenschr 2006; 156:380-385.
29. Huang W, Zhang J, Moore DD. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 2004; 113:137-143.
30. Marschall HU, Wagner M, Zollner G, Fickert P, Diczfalusy U, Gumhold J, et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 2005; 129:476-485.
31. Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, et al. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 2005; 42:420-430.
32. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 2004; 287:G1008-G1016.
33. Lee CH. Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated. Mol Cell Biochem 2001; 216:103-110.
34. Huang ZH, Murakami T, Okochi A, Yumoto R, Nagai J, Takano M. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur J Pharmacol 2000; 406:453-460.
35. Kunihara M, Nagai J, Murakami T, Takano M. Renal excretion of rhodamine 123, a P-glycoprotein substrate, in rats with glycerol-induced acute renal failure. J Pharm Pharmacol 1998; 50:1161-1165.
36. Jeyarajah DR, Kielar ML, Zhou XJ, Zhang Y, Lu CY. Acute bile duct ligation ameliorates ischemic renal failure. Nephron Physiol 2003; 95:28-35.
37. Masuda M, I'izuka Y, Yamazaki M, Nishigaki R, Kato Y, Ni'inuma K, et al. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res 1997; 57:3506-3510.
38. Paulusma CC, Kothe MJ, Bakker CT, Bosma PJ, van Bokhoven I, van Marle J, et al. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 2000; 31:684-693.
39. Zinchuk V, Zinchuk O, Okada T. Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: a quantitative colocalization study. Microsc Res Tech 2005; 67:65-70.
40. Kamisako T, Leier I. Characterization of ATP-dependent monoglucuronosyl bilirubin transport across rat canalicular membrane vesicles. Hepatol Res 2001; 19:103-107.
41. Rias IM, Johnson L, Wolfson S. Biliary excretion of injected conjugated and unconjugated bilirubin by normal and Gunn rats. Am J Physiol 1961; 200:1091-1094.
42. Jansen PL, Peters WH, Lamers WH. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985; 5:573-579.
43. Kurisu H, Kamisaka K, Koyo T, Yamasuge S, Igarashi H, Maezawa H, et al. Organic anion transport study in mutant rats with autosomal recessive conjugated hyperbilirubinemia. Life Sci 1991; 49:1003-1011.
44. Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996; 271:15091-15098.
45. Takada Y, Sano N, Takikawa H. Urinary excretion of bile acids in bile duct-ligated rats. J Gastroenterol 2003; 38:561-566.
46. Burchell B, Brierley CH, Rance D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci 1995; 57:1819-1831.
47. Dietrich CG, Geier A, Wasmuth HE, Matern S, Gartung C, de Waart DR, Elferink RP. Influence of biliary cirrhosis on the detoxification and elimination of a food derived carcinogen. Gut 2004; 53:1850-1855.